Enanta Pharmaceuticals Stock Forecast

Stock Analysis |
|
Risk Assessment |
|
Trading Strategy |
|
Red day on Friday for Enanta Pharmaceuticals
(Updated on Mar 14, 2025)
The Enanta Pharmaceuticals stock price fell by -2.64% on the last day (Friday, 14th Mar 2025) from $6.83 to $6.65. During the last trading day the stock fluctuated 5.87% from a day low at $6.64 to a day high of $7.03. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period. Volume has increased on the last day by 150 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 341 thousand shares were bought and sold for approximately $2.27 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.31 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 32.57% during the next 3 months and, with a 90% probability hold a price between $8.37 and $11.90 at the end of this 3-month period.

ENTA Signals & Forecast
A sell signal was issued from a pivot top point on Tuesday, February 25, 2025, and so far it has fallen -21.67%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Enanta Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $7.02. On a fall, the stock will find some support from the long-term average at approximately $6.60. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.
Support, Risk & Stop-loss for Enanta Pharmaceuticals stock
On the downside, the stock finds support just below today's level from accumulated volume at $5.85 and $5.75. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Enanta Pharmaceuticals finds support just below today's level at $5.85. If this is broken, then the next support from accumulated volume will be at $5.75 and $5.59.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.390 between high and low, or 5.87%. For the last week, the stock has had daily average volatility of 9.08%.
Enanta Pharmaceuticals is oversold on RSI14 (24). Some stock may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: $6.28 (-5.52%) (This stock has high daily movements and this gives high risk. Low RSI14 is 24 which reduces the risk some. There is a sell signal from a pivot top found 13 days ago.)
Trading Expectations (ENTA) For The Upcoming Trading Day Of Monday 17th
For the upcoming trading day on Monday, 17th we expect Enanta Pharmaceuticals to open at $6.77, and during the day (based on 14 day Average True Range), to move between $6.11 and $7.19, which gives a possible trading interval of +/-$0.543 (+/-8.17%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 16.34% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $5.85 (12.03%) than the resistance at $7.50 (12.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Enanta Pharmaceuticals stock A Buy?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
Current score:
1.809
Buy Candidate
Unchanged
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on March 17, 2025 - $6.77 ( 1.85%).ENTA Performance
Trading levels for ENTA
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 7.16 | 7.72% |
R2 | 7.01 | 5.48% |
R1 | 6.92 | 4.09% |
Price | 6.65 | |
S1 | 6.62 | -0.386% |
S2 | 6.53 | -1.77% |
S3 | 6.38 | -4.01% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 8.30 | 24.81% |
R2 | 8.03 | 20.75% |
R1 | 7.50 | 12.78% |
Price | 6.65 | |
S1 | 5.85 | -12.03% |
S2 | 5.75 | -13.53% |
S3 | 5.59 | -15.94% |
FAQ
Click here for our free guide on how to buy Enanta Pharmaceuticals Stock.